, a = 7.128(2) Â, b= 10.689(2)Â,c= 14.684(2)k,ß= 102.12(8)°, V= 1093.9 Â 3 , Ζ = 4, Rp(F) = 0.0614, wR^F 2 ) = 0.1680, 7= 113 K.
Source of material
Risedronate has been synthetized via a reaction between pyridinyl acetic acid, PCI3 and H3PO3 in chlorobenzene [ 1 ] . Crystallization was done by slow evaporation from chloridric acid solution (1 mol/1) at room temperature to give colorless crystals with max. size 0.1 mm.
and refined with the riding model in SHELXL with the U,» equal to 1.2 times of that of the preceding bonded atom. The anisotropic structure refinement did not produce significant progress and was not justified.
Discussion
Bisphosphonate drugs have been used successfully for the treatment of a variety of bone diseases such bone resorption, Paget's disease and postmenopausal osteoporosis [2] [3] [4] . Risedronate, a pyridinyl bisphosphonate, is member of nitrogen-containing bisphosphonate family, the new generation of oral bonetherapeutic drugs [5] . As most of the bisphosphonate structures, risedronate crystals are hydrated (mono hydrate). The free rotation for each PO3H2 group is blocked by intermolecular hydrogen bond. Bisphosphonate molecules are paired, and the water molecule takes a prominent part in the cohesion of the crystal structure, by building bridge between two bisphosphonate molecules with Η-O distances of 1.665 Â and 1.699 Â, O-O distances of2.488 Â and 2.704 Â, and O-H-O angles of 166.0° and 165.26°. The asymmetric unit contains a zwitterionic bisphosphonate moiety and one water molecule. Experimental details Diffraction data were collected at low temperature using synchrotron radiation (LURE, DW32 beam-line) with a MAR Research imaging-plate scanner. An unique data set, covering 470° rotation, was collected at 2 min exposure time to 0.95 À resolution with an oscillation angle per image of 5° (data completeness: 97.6 %; rsym : 8.1%). All H atoms were initially calculated at idealized positions C7H11NO7P2 h 2 O 
